You are here: Home / Sites / New York University School of Medicine / Pass, Harvey Ira

Pass, Harvey Ira (M.D.)

PI, New York University School of Medicine, 212-731-5414

Contact Information

Email: mailto:harvey.pass@med.nyu.edu
Fax: 212-263-5950
EDRN Principal Investigator

To update contact information, please visit the Data Management and Coordinating Center.

Open Protocols

Protocol Name Biomarkers Datasets
Utility of Biomarkers for Early Detection of Malignant Mesothelioma in a High-risk Population 0 0
Validation of Molecular Biomarkers for the Early Detection of Lung Cancer in the setting of Indeterminate Pulmonary Nodules (Lung Team Project #2) 0 0

Closed Protocols

Protocol Name Biomarkers Datasets
Soluble Mesothelin Related Peptide (SMRP) and Osteopontin (OPN) as Early Detection Markers for Malignant Mesothelioma (MM) 2 0
US-Turkey Cappadocia Mesothelioma Project 0 0
Standard Specimen Reference Set: Lung 0 0

Publications

Publication Name PubMed ID Journal
Increased osteonectin expression is associated with malignant transformation and tumor associated fibrosis in the lung. 15246191 Lung Cancer
Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters. 16966607 Proc. Natl. Acad. Sci. U.S.A.
TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. 16798876 Proc. Natl. Acad. Sci. U.S.A.
SV40 detection in human tumor specimens. 16267039 Cancer Res.
Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex. 16243798 Clin. Cancer Res.
Identification of intelectin overexpression in malignant pleural mesothelioma by serial analysis of gene expression (SAGE). 15777968 Lung Cancer
A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes. 17251920 Nat. Rev. Cancer
Osteopontin is linked to p65 and MMP-9 expression in pulmonary adenocarcinoma but not in malignant pleural mesothelioma. 17493236 Histopathology
Aberrant promoter methylation of insulin-like growth factor binding protein-3 gene in human cancers. 17096329 Int. J. Cancer
Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung. 15639718 Lung Cancer

To update protocols, publications, biomarkers, or science data, please contact the Informatics Center.

Addresses

Clinical Cancer Center 8, 160 East 34th Street
New York University School of Medicine

To update addresses, please visit the Data Management and Coordinating Center.

🔜 Data-Sci Workshop
The EDRN Biomarker Data Science Workshop is coming this August, 2020. More details available soon.
Announcement 03/17/2020

The EDRN Registration page will be available soon to register for the 35th EDRN Steering Committee Meeting, now scheduled to take place from June 30-July 2, 2020, in Tempe, AZ.
Announcement



 
This icon signifies that something is happening and we kindly ask you to please wait